| Line Item | 2025-11-30 | Y/Y |
|---|---|---|
| Revenue | $118.1M | +37.7% |
| Cost of Revenue | $46.6M | +41.4% |
| Gross Profit | $71.5M | +35.4% |
| R&D Expense | $300K | -50.0% |
| Operating Income | $11.8M | +77.5% |
| Pre-tax Income | $11.7M | +65.7% |
| Income Tax | $2.1M | +136.0% |
| Net Income | $9.7M | -24.3% |
| EPS (Basic) | $0.43 |
| Line Item | 2025-11-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.7M | -18.4% |
| Short-term Investments | $1.8M | -80.3% |
| Accounts Receivable | $10.8M | +312.2% |
| Inventory | $32.7M | +63.7% |
| Current Assets | $63.7M | +25.0% |
| Total Assets | $84.5M | +17.5% |
| Current Liabilities | $17.1M | +10.7% |
| Line Item | 2025-11-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.6M | -113.4% |
| Capital Expenditures | $7.6M | +224.8% |
| Investing Cash Flow | -$459K | +95.9% |
| Financing Cash Flow | -$1.3M | +70.7% |
| Free Cash Flow | -$9.2M | -197.9% |
| -24.6% |
| EPS (Diluted) | $0.40 | -27.3% |
| Total Liabilities |
| $18.7M |
| +6.7% |
| Stockholders' Equity | $65.8M | +20.9% |